Cardio Diagnostics Holdings partners with Navierre for cardiac testing

AI-enabled cardiovascular company Cardio Diagnostics Holdings announced it is partnering with care navigation platform Navierre to make assessing risk and diagnosing heart diseases more accessible.  Cardio Diagnostics Holdings’ AI solutions, Epi+GenCHD and PrecisionCHD, use blood samples to provide patients with personalized information regarding their risk for coronary heart disease based on epigenetic and genetic science. …

Read Full News